What Is Compounded Semaglutide?
Published Jun 29, 2026 · 5 minute read
Compounded semaglutide became one of the most talked-about topics in the GLP-1 world, often wrapped in confusion. This page explains what compounding actually is, why compounded GLP-1s appeared, and the cautions regulators have raised, without telling you what to do.
Key Takeaways
- Compounding is when a pharmacy prepares a customized medication rather than dispensing a manufacturer's finished product.
- Compounded semaglutide is not the same as FDA-approved Ozempic, Wegovy, or Rybelsus, and compounded products are not FDA-approved.
- Demand surged during brand shortages, which under U.S. rules can temporarily expand certain compounding.
- The FDA has warned about dosing errors and quality risks with compounded GLP-1 products, including non-standard salt forms.
- When a drug leaves the FDA shortage list, the rules around compounding it change.
- This page is educational and is not medical advice; it does not endorse or condemn any source.
1. What Is Compounding?
Compounding is when a licensed pharmacy prepares a customized medication for a patient, rather than dispensing a manufacturer’s finished, sealed product. It is a long-standing, regulated practice used, for example, to adjust a dose form or remove an allergen.
Compounded semaglutide means semaglutide prepared through that process, as opposed to the FDA-approved branded products: Ozempic, Wegovy, and Rybelsus.
| Term | What it means |
|---|---|
| Compounding | A pharmacy preparing a customized medication. |
| Compounded semaglutide | Semaglutide made via compounding, not by the brand manufacturer. |
| FDA-approved product | A finished drug whose manufacturing and labeling the FDA has reviewed. |
| Shortage list | The FDA’s list of drugs in short supply, which affects compounding rules. |
2. Compounded Is Not the Same as Approved
This is the most important distinction. An FDA-approved product like Ozempic has gone through a reviewed manufacturing and quality process. A compounded product, even one labeled “semaglutide,” has not been FDA-approved, and its preparation happens outside that review.
Same named ingredient does not mean same product, same quality controls, or same regulatory status.
3. Why Compounded GLP-1s Appeared
Two forces drove the surge:
- Shortages: when branded GLP-1s were in short supply, U.S. rules allowed certain compounding to help meet demand.
- Demand and price: intense interest in GLP-1s, combined with cost, created a large market for alternatives.
Crucially, the rules change when a drug comes off the FDA shortage list. Compounding that was permitted during a shortage may no longer be once supply recovers, which is why this area shifts over time.
4. Safety Cautions Regulators Have Raised
The FDA has publicly flagged several concerns with compounded and unapproved GLP-1 products:
- Dosing errors: people drawing and self-injecting from vials have made measurement mistakes, sometimes taking far more than intended.
- Non-standard ingredients: some products used semaglutide salt forms that differ from the approved active ingredient.
- Quality and sterility: because compounded products are not FDA-reviewed, accuracy, sterility, and purity can vary by source.
5. Compounded vs Brand vs Investigational
It helps to separate three categories that often get blurred:
| Category | Example | FDA-approved? |
|---|---|---|
| Branded, approved | Ozempic, Wegovy, Rybelsus | Yes |
| Compounded | Compounded semaglutide | No |
| Investigational | Retatrutide, VK2735 | No (in trials) |
Compounded and investigational products are both outside the approved category, but for different reasons: one is prepared by a pharmacy, the other is still being studied.
6. The Recordkeeping Angle
For anyone keeping personal logs, the key boundary is honesty about what is being recorded. A tracking record can note a product name, source, and dose a person enters, but it cannot verify quality, sterility, legality, or authenticity. See What Is a Peptide? and the peptide inventory tracking guide for how product and source notes are recorded without making quality claims.
- Compounded = pharmacy-prepared, not brand-manufactured.
- Not FDA-approved, unlike Ozempic, Wegovy, and Rybelsus.
- Shortage-driven, with rules that change as supply changes.
- Carries cautions the FDA has documented around dosing and quality.
7. Compounded Semaglutide FAQ
What does compounded semaglutide mean?
It means semaglutide prepared by a compounding pharmacy, which mixes or alters ingredients to make a customized product, rather than the finished, FDA-approved products made by Novo Nordisk (Ozempic, Wegovy, Rybelsus). Compounded versions are not FDA-approved.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Ozempic, Wegovy, and Rybelsus are FDA-approved branded products with a reviewed manufacturing process. Compounded semaglutide is prepared outside that process and is not FDA-approved, even if it contains the same named ingredient.
Why did compounded GLP-1 products become common?
When branded GLP-1s were in shortage, U.S. rules allowed certain compounding to help meet demand. That, combined with high prices and demand, drove a large market for compounded versions. The legal picture shifts as drugs move on and off the FDA shortage list.
What safety concerns has the FDA raised?
The FDA has reported dosing errors (often from people measuring and self-injecting from vials), and has flagged products using semaglutide salt forms that differ from the approved ingredient. Quality, sterility, and accuracy can vary because compounded products are not FDA-reviewed. This is general information, not medical advice.
Is compounded semaglutide legal?
Compounding itself is a regulated activity, but the rules depend on factors like shortage status, the type of pharmacy, and the exact ingredient used. This page explains the concept; it does not give legal or medical guidance on any specific product or source.